Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O43747: Variant p.Met366Val

AP-1 complex subunit gamma-1
Gene: AP1G1
Feedback?
Variant information Variant position: help 366 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Methionine (M) to Valine (V) at position 366 (M366V, p.Met366Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In USRISR; does not fully rescue morphological defects in a zebrafish animal model; affects trafficking of transferrin from recycling endosomes to plasma membrane; no effect on subcellular location in the perinuclear region; does not affect interaction with AP-1 complex subunits AP1B1, AP1M1 and AP1S1. Any additional useful information about the variant.


Sequence information Variant position: help 366 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 822 The length of the canonical sequence.
Location on the sequence: help HRSTIVDCLKDLDVSIKRRA M ELSFALVNGNNIRGMMKELL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         HRSTIVDCLKDLDVSIKRRAMELSFALVNGNNIRGMMKELL

Mouse                         HRSTIVDCLKDLDVSIKRRAMELSFALVNGNNIRGMMKELL

Baker's yeast                 HRKFISHCLQDTDVSIRMRALELSFAILDDSNLVELVNELM

Fission yeast                 HRSTILACLNDVDSSIQSRALELSTFLVNEANVRFMVRELL
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 822 AP-1 complex subunit gamma-1



Literature citations
De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy.
Usmani M.A.; Ahmed Z.M.; Magini P.; Pienkowski V.M.; Rasmussen K.J.; Hernan R.; Rasheed F.; Hussain M.; Shahzad M.; Lanpher B.C.; Niu Z.; Lim F.Y.; Pippucci T.; Ploski R.; Kraus V.; Matuszewska K.; Palombo F.; Kianmahd J.; Martinez-Agosto J.A.; Lee H.; Colao E.; Motazacker M.M.; Brigatti K.W.; Puffenberger E.G.; Riazuddin S.A.; Gonzaga-Jauregui C.; Chung W.K.; Wagner M.; Schultz M.J.; Seri M.; Kievit A.J.A.; Perrotti N.; Wassink-Ruiter J.S.K.; van Bokhoven H.; Riazuddin S.; Riazuddin S.;
Am. J. Hum. Genet. 108:1330-1341(2021)
Cited for: VARIANTS USRISD GLN-15; GLN-35; TRP-35 AND ARG-817; CHARACTERIZATION OF VARIANTS USRISD GLN-15; GLN-35; TRP-35 AND ARG-817; VARIANTS USRISR HIS-243 AND VAL-366; CHARACTERIZATION OF VARIANTS USRISR HIS-243 AND VAL-366; FUNCTION; SUBCELLULAR LOCATION; INVOLVEMENT IN USRISD; INVOLVEMENT IN USRISR;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.